[Cobalt teletherapy of patients with pharyngeal cancer].
127 patients with pharyngeal cancer were irradiated in the years 1970-1979 with telecobalt-60 in total doses of 60-65 Gy. In the group with not advanced pharyngeal cancer 34% of patients survived during 5 years without any symptoms of neoplasm. In the group with advanced pharyngeal cancer and lymph nodes metastases the 5 years survival was within 15%. The 5-years survival depended mainly upon the extensiveness of the neoplasm. The therapeutic results were influenced also by the age of the patient; 35% were above 60 years of age and 17.3% died before the 5 years period without any symptoms of cancer.
Zajusz
A
A
Wojcieszek
Z
Z
D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000209:etiology*; D009367:Neoplasm Staging; D010610:Pharyngeal Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy; D013997:Time Factors
D003037:Cobalt Radioisotopes
Telekobaltoterapia u chorych na raka gardła.